The mechanism of IFNß therapy in relapsing-remitting multiple sclerosis is not completely understood, however it is well known that its action starts with the interaction with IFNAR and the activation of the JAK and STAT proteins[26]. Here, SOAT1 is linked to relapsing-remitting multiple sclerosis.